Innate Pharma IPHA Estimates

NASDAQ IPHA
$2.30 +0.21 (+10.05%)
As of: Aug 21, 2026 · 10:29 AM EDT

Detailed analyst consensus, revenue, and earnings forecasts vs reported data.

Annual Revenue Estimates

Metric 202120222023202420252026202720282029
Reported (Actual) 28.08 M61.73 M68.04 M20.83 M10.58 M--
High Estimate 56.97 M83.75 M60.81 M41.10 M19.07 M26.49 M38.01 M
Low Estimate 52.70 M68.53 M56.43 M36.05 M16.71 M23.62 M34.32 M
Consensus Estimate 54.83 M76.14 M58.62 M38.58 M17.89 M25.06 M36.16 M

Annual Earnings Per Share (EPS) Estimates

Metric 202120222023202420252026202720282029
Reported (Actual) -0.63-0.79-0.10-0.66-0.63--
High Estimate -0.57-0.31-0.58-0.33-0.64-0.47-0.56
Low Estimate -0.67-0.35-0.68-0.37-0.70-0.51-0.66
Consensus Estimate -0.62-0.33-0.63-0.35-0.67-0.49-0.61